Cellular energy audit reveals energy producers and consumers

August 28, 2020

SAN FRANCISCO, CA--August 28, 2020-- TK Adenosine triphosphate, or ATP, is the cellular energy currency that is as valuable to the human body as the dollar is to the US economy. Too high or too low levels of ATP in some cell types have been linked to a variety of diseases. However, scientists have lacked an understanding of how cells regulate ATP levels on a broad scale and how cells' energy levels can be protected or restored in the setting of disease.

Now, researchers at Gladstone Institutes have performed a massive and detailed cellular energy audit; they analyzed every gene in the human genome to identify those that drive energy production or energy consumption. The result is a collection of data they call the "ATPome," which not only provides new directions for the field of metabolism research, but also identifies genes and proteins that can be targeted to manipulate cellular energy and treat disease.

"Essentially all cellular functions require energy but, before our study, we had very little knowledge about how to restore energy to cells when levels have gone awry," said Gladstone Associate Investigator Ken Nakamura, MD, PhD, the senior author of the study published online in the journal Nature Communications. "Our findings have implications for treating a broad array of disorders, including neurodegenerative diseases such as Parkinson's disease and Alzheimer's disease, mitochondrial disorders, heart disease, diabetes, and cancer."

When cells need energy, they turn the energy you consume in food into ATP molecules. Then, the cell breaks apart the ATP molecule to release the energy, which is used to fuel chemical reactions. When cells don't have enough ATP, disease can result. Dysregulated energy production may also play a central role in some cancers. But a lack of understanding of how cells regulate energy has made it difficult to target these energy imbalances therapeutically.

In the new study, Nakamura and his colleagues leveraged a screening approach they had previously developed that uses a chemical sensor to quantify how much ATP is present in individual cells. In addition, they turned to CRISPR gene-editing technology to selectively turn down--or turn up--the expression of nearly every gene in the human genome, one at a time. This way, the team could measure the effect of altering each gene on ATP levels. They repeated the experiments under three different metabolic conditions, forcing the cells to rely on different pathways to produce ATP.

The set of experiments revealed new genes and pathways that help boost cellular energy by either promoting energy production or slowing energy consumption. It also showed that the cell's fuel source is a critical factor in determining which genes are needed to maintain ATP levels.

"Before this study, we knew a lot more about how energy is produced than about how it is consumed," said Neal Bennett, PhD, a Gladstone postdoctoral scholar and first author of the study. "A better understanding of how energy is consumed could lead to truly novel ways of regulating ATP levels in diseases of energy dysregulation. For instance, in diseases such as stroke or heart attack where cells experience an acute deficiency of energy supply, our study may point to ways to temporarily preserve energy levels by reducing the amount of energy they consume."

The team was also surprised to observe a new role for a critical molecular pathway called HIF1. The pathway has long been linked to the production of ATP when cells are in low-oxygen conditions. But Nakamura's group found that the HIF1 pathway strongly suppresses ATP production even under normal oxygen conditions. This means that putting the brakes on HIF1 could be one way to increase energy production by mitochondria.

Nakamura believes that the new ATPome database his group generated will likely have far-reaching utility for scientists studying the role of cellular energy in disease. Being able to manipulate cellular energy could help biologists limit the amount of energy available to cancer cells, or increase ATP in brain cells affected by neurodegeneration, among other therapeutic applications.

"What we've done is put together a basic blueprint for how genes play a role in energy production, consumption, and possibly energy dysfunction," said Nakamura, who is also an associate professor of neurology at UC San Francisco (UCSF). "From here, we have to extend the results into other cell types and gain an understanding of how this basic blueprint is altered by different diseases, in order to develop novel therapeutic approaches to manipulate energy metabolism."

Nakamura's lab is collaborating with other researchers at Gladstone and UCSF to study how energy usage might differ in brains affected by Parkinson's or Alzheimer's disease; in the heart--an organ that requires high amounts of energy and is prone to energy failure; and in cancer, which may be fueled by excessive energy.
-end-
About the Study

The paper "Defining the ATPome Reveals Cross Optimization of Metabolic Pathways" was published by the journal Nature Communications on August 28, 2020: https://www.nature.com/articles/s41467-020-18084-6.

Co-authors include Mai Nguyen, Maxwell Darch, Derek Cousineau, and Bryce Mendelsohn of Gladstone; Hiroki Nakaoka, Emin Maltepe, Martin Kampmann, and Jean Nakamura of UC San Francisco; Johanna ten Hoeve and Thomas Graeber of University of California, Los Angeles; and Markus Schuelke of Charité-Universitätsmedizin Berlin.

The work and researchers involved were supported by Shire Human Genetic Therapies Inc, a member of the Takeda group of companies, the Joan and David Traitel Family Trust, Betty Brown's Family, the National Institutes of Health (RO1NS091902, F32 AG0634557-01, U54CA196519, DP2 GM119139, RO1HD072455, S10 OD016387), a Berkelhammer Award for Excellence in Neuroscience, the Pediatric Scientist Development Program (K12-HD000850), and the Chan Zuckerberg Biohub.

About Gladstone Institutes

To ensure our work does the greatest good, Gladstone Institutes (http://gladstone.org) focuses on conditions with profound medical, economic, and social impact--unsolved diseases. Gladstone is an independent, nonprofit life science research organization that uses visionary science and technology to overcome disease.

Gladstone Institutes

Related Human Genome Articles from Brightsurf:

240 mammals help us understand the human genome
A large international consortium led by scientists at Uppsala University and the Broad Institute of MIT and Harvard has sequenced the genome of 130 mammals and analysed the data together with 110 existing genomes to allow scientist to identify which are the important positions in the DNA.

The National Human Genome Research Institute publishes new vision for human genomics
The National Human Genome Research Institute this week published its 'Strategic vision for improving human health at The Forefront of Genomics' in the journal Nature.

Interpreting the human genome's instruction manual
Berkeley Lab bioscientists are part of a nationwide research project, called ENCODE, that has generated a detailed atlas of the molecular elements that regulate our genes.

3-D shape of human genome essential for robust inflammatory response
The three-dimensional structure of the human genome is essential for providing a rapid and robust inflammatory response but is surprisingly not vital for reprogramming one cell type into another.

The genome of chimpanzees and gorillas could help to better understand human tumors
A new study by researchers from the Institute of Evolutionary Biology (IBE), a joint center of UPF and the Spanish National Research Council (CSIC), shows that, surprisingly, the distribution of mutations in human tumors is more similar to that of chimpanzees and gorillas than that of humans.

It's in our genome: Uncovering clues to longevity from human genetics
Researchers from Osaka University found that high blood pressure and obesity are the strongest factors reducing lifespan based on genetic and clinical information of 700,000 patients in the UK, Finland and Japan.

New limits to functional portion of human genome reported
An evolutionary biologist at the University of Houston has published new calculations that indicate no more than 25 percent of the human genome is functional.

Synthesizing the human genome from scratch
For the past 15 years, synthetic biologists have been figuring out how to synthesize an organism's complete set of DNA, including all of its genes.

Science and legal experts debate future uses and impact of human genome editing in Gender & the Genome
Precise, economical genome editing tools such as CRISPR have made it possible to make targeted changes in genes, which could be applied to human embryos to correct mutations, prevent disease, or alter traits.

Evolution purged many Neanderthal genes from human genome
Neanderthal genetic material is found in only small amounts in the genomes of modern humans because, after interbreeding, natural selection removed large numbers of weakly deleterious Neanderthal gene variants, according to a study by Ivan Juric and colleagues at the University of California, Davis, published Nov.

Read More: Human Genome News and Human Genome Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.